Literature DB >> 29055821

Prevalence and pathways of recovery from drug and alcohol problems in the United States population: Implications for practice, research, and policy.

John F Kelly1, Brandon Bergman2, Bettina B Hoeppner2, Corrie Vilsaint2, William L White3.   

Abstract

BACKGROUND: Alcohol and other drug (AOD) problems confer a global, prodigious burden of disease, disability, and premature mortality. Even so, little is known regarding how, and by what means, individuals successfully resolve AOD problems. Greater knowledge would inform policy and guide service provision.
METHOD: Probability-based survey of US adult population estimating: 1) AOD problem resolution prevalence; 2) lifetime use of "assisted" (i.e., treatment/medication, recovery services/mutual help) vs. "unassisted" resolution pathways; 3) correlates of assisted pathway use. Participants (response=63.4% of 39,809) responding "yes" to, "Did you use to have a problem with alcohol or drugs but no longer do?" assessed on substance use, clinical histories, problem resolution.
RESULTS: Weighted prevalence of problem resolution was 9.1%, with 46% self-identifying as "in recovery"; 53.9% reported "assisted" pathway use. Most utilized support was mutual-help (45.1%,SE=1.6), followed by treatment (27.6%,SE=1.4), and emerging recovery support services (21.8%,SE=1.4), including recovery community centers (6.2%,SE=0.9). Strongest correlates of "assisted" pathway use were lifetime AOD diagnosis (AOR=10.8[7.42-15.74], model R2=0.13), drug court involvement (AOR=8.1[5.2-12.6], model R2=0.10), and, inversely, absence of lifetime psychiatric diagnosis (AOR=0.3[0.2-0.3], model R2=0.10). Compared to those with primary alcohol problems, those with primary cannabis problems were less likely (AOR=0.7[0.5-0.9]) and those with opioid problems were more likely (AOR=2.2[1.4-3.4]) to use assisted pathways. Indices related to severity were related to assisted pathways (R2<0.03).
CONCLUSIONS: Tens of millions of Americans have successfully resolved an AOD problem using a variety of traditional and non-traditional means. Findings suggest a need for a broadening of the menu of self-change and community-based options that can facilitate and support long-term AOD problem resolution.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Adults; Assisted; Mutual-help; Population; Prevalence; Problem resolution; Recovery; Treatment; Unassisted

Mesh:

Year:  2017        PMID: 29055821      PMCID: PMC6076174          DOI: 10.1016/j.drugalcdep.2017.09.028

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  48 in total

Review 1.  Actual causes of death in the United States, 2000.

Authors:  Ali H Mokdad; James S Marks; Donna F Stroup; Julie L Gerberding
Journal:  JAMA       Date:  2004-03-10       Impact factor: 56.272

2.  Deconstructing the age-prevalence curve of alcohol dependence: why "maturing out" is only a small piece of the puzzle.

Authors:  Alvaro Vergés; Kristina M Jackson; Kathleen K Bucholz; Julia D Grant; Timothy J Trull; Phillip K Wood; Kenneth J Sher
Journal:  J Abnorm Psychol       Date:  2011-11-07

3.  Elements that define recovery: the experiential perspective.

Authors:  Lee Ann Kaskutas; Thomasina J Borkman; Alexandre Laudet; Lois A Ritter; Jane Witbrodt; Meenakshi Sabina Subbaraman; Aina Stunz; Jason Bond
Journal:  J Stud Alcohol Drugs       Date:  2014-11       Impact factor: 2.582

4.  Psychosocial treatments for cocaine dependence: National Institute on Drug Abuse Collaborative Cocaine Treatment Study.

Authors:  P Crits-Christoph; L Siqueland; J Blaine; A Frank; L Luborsky; L S Onken; L R Muenz; M E Thase; R D Weiss; D R Gastfriend; G E Woody; J P Barber; S F Butler; D Daley; I Salloum; S Bishop; L M Najavits; J Lis; D Mercer; M L Griffin; K Moras; A T Beck
Journal:  Arch Gen Psychiatry       Date:  1999-06

5.  Gender and race/ethnic differences in the persistence of alcohol, drug, and poly-substance use disorders.

Authors:  Elizabeth A Evans; Christine E Grella; Donna L Washington; Dawn M Upchurch
Journal:  Drug Alcohol Depend       Date:  2017-03-07       Impact factor: 4.492

6.  The "Biopsychosocial Model": 40 years of application in Psychiatry.

Authors:  G Papadimitriou
Journal:  Psychiatriki       Date:  2017 Apr-Jun

Review 7.  Is Alcoholics Anonymous religious, spiritual, neither? Findings from 25 years of mechanisms of behavior change research.

Authors:  John F Kelly
Journal:  Addiction       Date:  2016-10-08       Impact factor: 6.526

8.  Trends in the treatment of alcohol problems in the US general population, 1979 through 1990.

Authors:  C Weisner; T Greenfield; R Room
Journal:  Am J Public Health       Date:  1995-01       Impact factor: 9.308

9.  The Prescription Opioid Addiction Treatment Study: What have we learned.

Authors:  Roger D Weiss; Vinod Rao
Journal:  Drug Alcohol Depend       Date:  2017-04-01       Impact factor: 4.492

10.  Online consumer surveys as a methodology for assessing the quality of the United States health care system.

Authors:  Christina Bethell; John Fiorillo; David Lansky; Michael Hendryx; James Knickman
Journal:  J Med Internet Res       Date:  2004-01-20       Impact factor: 5.428

View more
  37 in total

1.  Attitudes toward opioid use disorder medications: Results from a U.S. national study of individuals who resolved a substance use problem.

Authors:  Brandon G Bergman; Robert D Ashford; John F Kelly
Journal:  Exp Clin Psychopharmacol       Date:  2019-09-26       Impact factor: 3.157

2.  Whether, when, and to whom?: An investigation of comfort with disclosing alcohol and other drug histories in a nationally representative sample of recovering persons.

Authors:  Valerie A Earnshaw; Brandon G Bergman; John F Kelly
Journal:  J Subst Abuse Treat       Date:  2019-03-25

3.  Stigma and substance use disorders: A clinical, research, and advocacy agenda.

Authors:  Valerie A Earnshaw
Journal:  Am Psychol       Date:  2020-12

4.  Biased labels: An experimental study of language and stigma among individuals in recovery and health professionals.

Authors:  Robert D Ashford; Austin M Brown; Jessica McDaniel; Brenda Curtis
Journal:  Subst Use Misuse       Date:  2019-04-04       Impact factor: 2.164

5.  One-Stop Shopping for Recovery: An Investigation of Participant Characteristics and Benefits Derived From U.S. Recovery Community Centers.

Authors:  John F Kelly; Robert L Stout; Leonard A Jason; Nilofar Fallah-Sohy; Lauren A Hoffman; Bettina B Hoeppner
Journal:  Alcohol Clin Exp Res       Date:  2020-02-03       Impact factor: 3.455

6.  Smoking cessation in the context of recovery from drug and alcohol problems: Prevalence, predictors, and cohort effects in a national U.S. sample.

Authors:  John F Kelly; M Claire Greene; Brandon Bergman; Bettina Hoeppner
Journal:  Drug Alcohol Depend       Date:  2018-12-08       Impact factor: 4.492

7.  Digital recovery networks: Characterizing user participation, engagement, and outcomes of a novel recovery social network smartphone application.

Authors:  Robert D Ashford; Salvatore Giorgi; Beau Mann; Chris Pesce; Lon Sherritt; Lyle Ungar; Brenda Curtis
Journal:  J Subst Abuse Treat       Date:  2019-11-15

8.  Is recovery from cannabis use problems different from alcohol and other drugs? Results from a national probability-based sample of the United States adult population.

Authors:  John F Kelly; M Claire Greene; Brandon G Bergman
Journal:  Int J Drug Policy       Date:  2017-12-26

9.  From working on recovery to working in recovery: Employment status among a nationally representative U.S. sample of individuals who have resolved a significant alcohol or other drug problem.

Authors:  David Eddie; Corrie L Vilsaint; Lauren A Hoffman; Brandon G Bergman; John F Kelly; Bettina B Hoeppner
Journal:  J Subst Abuse Treat       Date:  2020-03-09

10.  Perceived discrimination in addiction recovery: Assessing the prevalence, nature, and correlates using a novel measure in a U.S. National sample.

Authors:  Corrie L Vilsaint; Lauren A Hoffman; John F Kelly
Journal:  Drug Alcohol Depend       Date:  2019-10-25       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.